NEW YORK – Mission Bio and Alliance Global (AGBL) said on Thursday that they have entered into an agreement for Alliance to exclusively distribute Mission's products, such as its single-cell sequencing Tapestri platform, throughout the Middle East and Africa.
The deal builds on Mission Bio's recent efforts to broaden its global reach. The South San Francisco, California-based company partnered with Sequanta Technologies in July, for example, to provide single-cell sequencing services to mainland China. Prior to that, the firm had also signed a deal with Bioké to distribute Tapestri throughout the Netherlands, Belgium, and Luxembourg.
"AGBL has a history of bringing new and innovative technologies to Middle East and African countries as evidenced by their previous success in commercializing hundreds of next-generation sequencers, and supporting all the national population genetics projects in the region," Darrin Crisitello, chief commercial officer of Mission Bio, said in a statement.
"Mission Bio's Tapestri single-cell sequencing platform is an important addition to AGBL's portfolio of genomics products," said Tamer Degheidy, CEO and co-founder of AGBL. "We are very excited about developing the use of the Tapestri platform in our clinical laboratories."